FDA-Drug2026-07-29Class IIMISBRANDING
Major Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
What this means
Major Pharmaceuticals issued a recall of Levothyroxine Sodium Tablets, USP, 88 mcg (Lot #N02310, expiration 01/2027) because the tablets may contain less active ingredient than labeled. This means patients taking this medication may not receive the full intended dose of thyroid hormone.
- If you take this medication, contact your pharmacy or doctor to confirm whether you have the recalled lot.
- Do not stop taking your levothyroxine without talking to your doctor—stopping suddenly can cause serious health problems.
- Your pharmacy can provide a replacement from a different lot or manufacturer.
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0703-2026More Major Pharmaceuticals recalls
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 112 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine 25 mcg tablets recalled for subpotency
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.